Age
Sleep Heart Health Study (SHHS) Visit Number vs Maximum duration of central apnea in REM sleep in supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Visit 1 | 264 | 21.0 | ± 12.2 | 18.0 | 9.0 | 88.0 | 5,540 | 5,804 |
| Interim Follow-up Visit | - | - | - | - | - | - | - | - |
| Visit 2 | 222 | 18.3 | ± 7.6 | 17.0 | 9.0 | 50.0 | 3,858 | 4,080 |
| CVD Outcomes | - | - | - | - | - | - | - | - |
Age at Sleep Heart Health Study Visit One (SHHS1) vs Maximum duration of central apnea in REM sleep in supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 264 | 21.0 | ± 12.2 | 18.0 | 9.0 | 88.0 | 5,540 | 5,804 |
| 35-44 years | 18 | 20.2 | ± 8.7 | 17.5 | 12.0 | 41.0 | 324 | 342 |
| 45-54 years | 41 | 17.0 | ± 8.1 | 14.0 | 10.0 | 48.0 | 976 | 1,017 |
| 55-64 years | 87 | 19.0 | ± 8.1 | 17.0 | 10.0 | 65.0 | 1,682 | 1,769 |
| 65-74 years | 67 | 21.0 | ± 10.6 | 18.0 | 9.0 | 64.0 | 1,550 | 1,617 |
| 75-84 years | 49 | 28.4 | ± 19.4 | 21.0 | 11.0 | 88.0 | 906 | 955 |
| 85 years or older | 2 | 20.0 | ± 12.7 | 20.0 | 11.0 | 29.0 | 102 | 104 |
Gender of the participant vs Maximum duration of central apnea in REM sleep in supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 264 | 21.0 | ± 12.2 | 18.0 | 9.0 | 88.0 | 5,540 | 5,804 |
| Male | 148 | 23.1 | ± 13.7 | 19.0 | 10.0 | 88.0 | 2,617 | 2,765 |
| Female | 116 | 18.4 | ± 9.3 | 16.0 | 9.0 | 84.0 | 2,923 | 3,039 |
Gender of the participant vs Maximum duration of central apnea in REM sleep in supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 2
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 222 | 18.3 | ± 7.6 | 17.0 | 9.0 | 50.0 | 3,858 | 4,080 |
| Male | 117 | 19.3 | ± 8.4 | 17.0 | 9.0 | 50.0 | 1,744 | 1,861 |
| Female | 105 | 17.1 | ± 6.4 | 15.0 | 10.0 | 47.0 | 2,114 | 2,219 |
Race of the participant vs Maximum duration of central apnea in REM sleep in supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 1
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 264 | 21.0 | ± 12.2 | 18.0 | 9.0 | 88.0 | 5,540 | 5,804 |
| White | 220 | 21.7 | ± 12.7 | 18.0 | 9.0 | 88.0 | 4,687 | 4,907 |
| Black | 21 | 18.5 | ± 8.9 | 14.0 | 11.0 | 42.0 | 494 | 515 |
| Other | 23 | 17.5 | ± 7.9 | 14.0 | 10.0 | 35.0 | 359 | 382 |
Race of the participant vs Maximum duration of central apnea in REM sleep in supine position: Central apneas with >= 3% oxygen desaturation threshold used and with or without arousal from type II polysomnography
Visit 2
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 222 | 18.3 | ± 7.6 | 17.0 | 9.0 | 50.0 | 3,858 | 4,080 |
| White | 193 | 18.1 | ± 7.5 | 17.0 | 9.0 | 50.0 | 3,394 | 3,587 |
| Black | 13 | 19.8 | ± 9.6 | 16.0 | 11.0 | 47.0 | 243 | 256 |
| Other | 16 | 18.6 | ± 6.8 | 16.5 | 11.0 | 35.0 | 221 | 237 |